Amrize Proposes $486.7M in Special and Regular Shareholder Distributions
AMRZ sits 47% above its 52-week low of $44.12.
Summary
Amrize Ltd. filed its preliminary proxy statement, proposing shareholder approval for a total of $0.88 per share in special and regular distributions from legal reserves, totaling approximately $486.7 million.
Key Events · Corporate Governance and Compliance · AMRZ
-
Proposed Shareholder Distributions
Shareholders will vote on a special distribution of $0.44 per share and a regular distribution of up to $0.44 per share, both from legal reserves.
-
Significant Capital Return
The total proposed distributions amount to approximately $486.7 million, representing a notable return of capital to shareholders, equivalent to about 1.35% of the company's market capitalization.
-
Annual General Meeting Agenda
The filing details proposals for the 2026 AGM, including the re-election of all nine directors, approval of executive and board compensation, and ratification of auditor appointments.
-
Material Weakness Reiteration
The filing reiterates the material weakness in internal controls over financial reporting, which was previously disclosed in the 2025 10-K filed on February 18, 2026.
Analysis · AMRZ · Manufacturing
This preliminary proxy statement outlines the agenda for Amrize's 2026 Annual General Meeting, with the most significant item being the proposed distributions to shareholders. The company is seeking approval for a special distribution of $0.44 per share and a regular distribution of up to $0.44 per share, both from legal reserves. This combined $0.88 per share distribution represents a substantial return of capital to shareholders, totaling approximately $486.7 million based on 553,082,525 outstanding shares. This follows the company's recent 10-K filing which mentioned a share repurchase program and dividends, and this filing provides the specific, material amounts for these distributions. The filing also includes routine proposals for the re-election of the Board and Executive Management compensation for 2027, and reiterates the previously disclosed material weakness in internal controls.
At the time of this filing, AMRZ was trading at $64.99 on NYSE in the Manufacturing sector, with a market capitalization of approximately $35.9B. The 52-week trading range was $44.12 to $65.94. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.